Total Payments
$15,241
2024 Payments
$109.94
Companies
45
Transactions
858
Medicare Patients
1,145
Medicare Billing
$66,517
Payment Breakdown by Category
Food & Beverage$15,198 (99.7%)
Education$43.44 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,198 | 850 | 99.7% |
| Education | $43.44 | 8 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,454 | 86 | $0 (2023) |
| ABBVIE INC. | $1,453 | 84 | $0 (2023) |
| Novo Nordisk Inc | $1,416 | 103 | $0 (2023) |
| Amarin Pharma Inc. | $1,154 | 76 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $912.76 | 46 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $823.96 | 12 | $0 (2021) |
| Amgen Inc. | $755.09 | 44 | $0 (2024) |
| GlaxoSmithKline, LLC. | $744.58 | 53 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $660.05 | 16 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $659.41 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109.94 | 6 | Amgen Inc. ($91.01) |
| 2023 | $1,011 | 60 | ABBVIE INC. ($207.22) |
| 2022 | $2,736 | 138 | Biohaven Pharmaceutical Holding Company Ltd. ($660.05) |
| 2021 | $3,399 | 149 | Biohaven Pharmaceuticals, Inc. ($823.96) |
| 2020 | $1,554 | 89 | PFIZER INC. ($374.88) |
| 2019 | $2,007 | 124 | PFIZER INC. ($399.29) |
| 2018 | $1,967 | 135 | Janssen Pharmaceuticals, Inc ($337.51) |
| 2017 | $2,457 | 157 | Novo Nordisk Inc ($359.48) |
All Payment Transactions
858 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/02/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/20/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $18.93 | General |
| 07/18/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Biological | ||||||
| 07/10/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Diabetes | ||||||
| 07/06/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: RESPIRATORY | ||||||
| 07/03/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Diabetes Care | ||||||
| 06/27/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: VACCINES | ||||||
| 06/23/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.51 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Biological | ||||||
| 06/13/2023 | Merck Sharp & Dohme LLC | VAXELIS (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: VACCINE | ||||||
| 06/13/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Endocrinology | ||||||
| 06/06/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Neuroscience | ||||||
| 05/26/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Cardio-renal | ||||||
| 05/23/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: UROLOGY | ||||||
| 05/22/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Oncology | ||||||
| 05/22/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 109 | 156 | $22,876 | $4,693 |
| 2022 | 9 | 316 | 448 | $54,609 | $13,412 |
| 2021 | 9 | 333 | 498 | $63,233 | $25,162 |
| 2020 | 13 | 387 | 550 | $58,133 | $23,250 |
Total Patients
1,145
Total Services
1,652
Medicare Billing
$66,517
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 64 | $10,560 | $2,377 | 22.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 27 | 27 | $6,426 | $1,207 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 21 | $4,914 | $731.12 | 14.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 32 | $832.00 | $304.64 | 36.6% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 11 | 12 | $144.00 | $73.32 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 126 | $20,790 | $4,879 | 23.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 57 | 57 | $13,566 | $2,520 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 53 | $12,402 | $1,986 | 16.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 17 | 17 | $2,180 | $1,162 | 53.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 54 | 54 | $1,674 | $940.31 | 56.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 39 | 39 | $1,209 | $692.58 | 57.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 27 | 68 | $1,768 | $651.46 | 36.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $816.00 | $475.72 | 58.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 16 | 17 | $204.00 | $104.77 | 51.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 155 | $25,275 | $8,301 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 62 | 62 | $14,006 | $7,977 | 57.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 70 | $16,056 | $5,055 | 31.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 18 | 18 | $2,250 | $1,175 | 52.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 49 | 49 | $1,519 | $872.69 | 57.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 39 | 39 | $1,209 | $694.59 | 57.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 31 | 67 | $1,742 | $650.57 | 37.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 20 | 20 | $960.00 | $323.80 | 33.7% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 15 | 18 | $216.00 | $112.14 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 66 | 66 | $13,728 | $7,396 | 53.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 64 | 141 | $19,035 | $6,153 | 32.3% |
About Dr. James Johnston, D.O
Dr. James Johnston, D.O is a Family Medicine healthcare provider based in Cuyahoga Falls, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669486817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Johnston, D.O has received a total of $15,241 in payments from pharmaceutical and medical device companies, with $109.94 received in 2024. These payments were reported across 858 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($15,198).
As a Medicare-enrolled provider, Johnston has provided services to 1,145 Medicare beneficiaries, totaling 1,652 services with total Medicare billing of $66,517. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Cuyahoga Falls, OH
- Active Since 07/27/2006
- Last Updated 03/22/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1669486817
Products in Payments
- NURTEC ODT (Drug) $1,484
- Vascepa (Drug) $1,154
- VRAYLAR (Drug) $722.21
- UBRELVY (Drug) $608.08
- XARELTO (Drug) $526.68
- FARXIGA (Drug) $512.45
- COLOGUARD (Device) $453.19
- Victoza (Drug) $391.66
- ELIQUIS (Drug) $323.08
- CHANTIX (Drug) $318.30
- XIFAXAN (Drug) $317.95
- Kerendia (Drug) $300.26
- AFREZZA (Drug) $292.47
- TRULICITY (Drug) $292.30
- Ozempic (Drug) $289.58
- Aimovig (Biological) $288.80
- Saxenda (Drug) $243.48
- JARDIANCE (Drug) $220.22
- SOLIQUA 100/33 (Biological) $217.76
- JANUVIA (Drug) $215.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cuyahoga Falls
Dr. Tricia Bedrick, D.o, D.O
Family Medicine — Payments: $223,294
Family Medicine $223,294
Muhamad Musa, M.d, M.D
Family Medicine — Payments: $19,605
Family Medicine $19,605
Dr. Scott Higley, D.o, D.O
Family Medicine — Payments: $16,424
Family Medicine $16,424
William Schukay, Do, DO
Family Medicine — Payments: $16,108
Family Medicine $16,108
Victoria Digennaro, D.o, D.O
Family Medicine — Payments: $13,874
Family Medicine $13,874
Andrea Cerone, M.d, M.D
Family Medicine — Payments: $12,005
Family Medicine $12,005